Biotech Values

[jmkobers]

Perhaps, but I see marginally competent leadership being successful selling this drug, and since I believe the company wants to be sold, I believe it will happen at right price. Going back to the 100ml vial debacle which led to the covid delays, all the way until now, there is a lack of urgency/common sense, root of which I believe is related to the river of money provided by street consistently over the years. Have worked in IT for small start ups that took the street's money, and those that didn't. In time, those that do get complacent, lose focus, and lose their edge. RVNC should be 2 yrs into sales at worst, at best be sold by now. In sum, leadership seems to think if their sell price is off the table and not close for now, what's the hurry?

Assuming you have an opinion because you responded, what's your take on the company?